Rating Change
Citizens reiterated its Market Outperform rating on TuHURA Biosciences, Inc. (NASDAQ:HURA) on August 18, 2026.
reiterateNASDAQ:HURA
Citizens Reiterates Market Outperform Rating on TuHURA Biosciences, Inc. (HURA)
Citizens reiterated its Market Outperform rating on TuHURA Biosciences, Inc. (NASDAQ:HURA) on August 18, 2026.
At publication ·
What changed
TuHURA Biosciences, Inc. (NASDAQ:HURA) · reiterate
- Firm
- Citizens
- Rating
- Market Outperform to Market Outperform
- Price at event
- $2.16
- Market capitalization
- $52.9M
At a glance
Key takeaways
- Citizens reiterated a Market Outperform rating on TuHURA Biosciences (HURA) on August 18, 2026, with the stock trading at $2.16 and a market capitalization of $52.9 million.
Market Context
TuHURA Biosciences, Inc. operates in the Healthcare sector. The stock currently trades at $2.16 with a market capitalization of $52.9M. The stock has declined 17.4% over the past 52 weeks.
Analyst coverage from Citizens provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for TuHURA Biosciences, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for TuHURA Biosciences, Inc.
Among the 9 most recent ratings: 9 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 18, 2026 | Citizens | Market Outperform | N/A |
| Apr 27, 2026 | Citizens | Market Outperform | N/A |
| Feb 03, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jan 09, 2026 | HC Wainwright & Co. | Buy | N/A |
| Nov 14, 2025 | Maxim Group | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View HURA Stock Page
Frequently Asked Questions
What does the Market Outperform rating mean for HURA?
A rating of Market Outperform from Citizens reflects the analyst's outlook on TuHURA Biosciences, Inc. (NASDAQ:HURA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HURA forecast page.